Legend Biotech Corporation
LEGN
$35.06
$0.3551.02%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 159.92M | 184.10M | 90.66M | 79.42M | 95.99M |
| Total Other Revenue | 281.00K | 2.42M | 3.33M | 41.00K | 19.00K |
| Total Revenue | 160.21M | 186.52M | 93.99M | 79.46M | 96.01M |
| Cost of Revenue | 150.99M | 163.08M | 155.70M | 138.13M | 139.33M |
| Gross Profit | 9.21M | 23.45M | -61.71M | -58.67M | -43.32M |
| SG&A Expenses | 79.57M | 65.42M | 56.15M | 62.38M | 49.20M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 230.56M | 228.49M | 211.86M | 200.52M | 188.54M |
| Operating Income | -70.36M | -41.97M | -117.86M | -121.05M | -92.52M |
| Income Before Tax | -120.89M | -17.97M | -59.79M | -146.81M | -62.50M |
| Income Tax Expenses | 4.44M | 226.00K | 5.00K | -1.99M | -288.00K |
| Earnings from Continuing Operations | -125.32M | -18.20M | -59.79M | -144.82M | -62.21M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -125.32M | -18.20M | -59.79M | -144.82M | -62.21M |
| EBIT | -70.36M | -41.97M | -117.86M | -121.05M | -92.52M |
| EBITDA | -67.98M | -39.19M | -115.07M | -118.33M | -89.85M |
| EPS Basic | -1.37 | -0.20 | -0.66 | -1.59 | -0.69 |
| Normalized Basic EPS | -0.41 | -0.06 | -0.21 | -0.50 | -0.22 |
| EPS Diluted | -1.37 | -0.20 | -0.66 | -1.60 | -0.69 |
| Normalized Diluted EPS | -0.41 | -0.06 | -0.21 | -0.50 | -0.22 |
| Average Basic Shares Outstanding | 183.28M | 182.60M | 182.01M | 181.83M | 181.54M |
| Average Diluted Shares Outstanding | 91.64M | 91.30M | 91.00M | 90.91M | 90.77M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
